• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Keywords » women's_issues_in_psychiatry

Items Tagged with 'women's_issues_in_psychiatry'

ARTICLES

Prevalence of Fetal Alcohol Spectrum Disorder

May 1, 2018
Christian J. Teter, PharmD, BCPP
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Christian J. Teter, PharmD, BCPP Dr. Teter has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
New evidence suggests that the prevalence of fetal alcohol spectrum disorder is higher than previously documented. In this study, prevalence estimates were derived from 13,146 first-grade children in four U.S. communities between 2010 and 2016.
Read More

Estrogen Modulator Raloxifene Not Helpful for Schizophrenic Women

January 1, 2018
Robert T. Rubin, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Robert T. Rubin, MD Dr. Rubin has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Since estrogen can affect neurotransmitter functioning, there has been some interest in using estrogen modulators to treat psychiatric conditions, including schizophrenia. Raloxifene is a selective estrogen receptor modulator (SERM) with some preliminary evidence for effectiveness in women with schizophrenia.
Read More

Substance Use in Pregnancy: What to Tell Patients

November 1, 2017
Cresta Wedel Jones, MD, FACOG
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Cresta Wedel Jones, MD, FACOG Maternal-fetal medicine physician and assistant professor at the University of Minnesota Medical School. Dr. Jones has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
In this article, I’ll start by briefly outlining what the research tells us about the risks of substance use to the fetus. The more informed you are about these risks, the more persuasive and helpful you can be to patients. I’ll then move on to discussing how, as an OB/GYN, I approach the evaluation and treatment of these patients, emphasizing issues of interest to clinicians.
Read More

Pregnancy and Substance Use Disorders

November 1, 2017
Carl Christensen, MD, PhD 
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information
Carl Christensen, MD, PhD  Principal, Christensen Recovery Services, Ann Arbor, MI. Dr. Christensen has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Typically, the most frequent problem that I’m referred is the pregnant patient who’s dependent on opioids. And this could be either someone who’s using illicit drugs, such as heroin, or is prescribed prescription opioids.
Read More

What’s New with the FDA Labeling for Pregnancy and Lactation?

July 25, 2016
Talia Puzantian, PharmD, BCPP
We’ve been hearing for some time now about the FDA’s plans to revise the long-standing categories A, B, C, D, and X designations for risk of using medications in pregnancy. The new rule (referred to as PLLR for Pregnancy and Lactation Labeling Rule) was proposed in 2008, finalized in 2014,...
Read More

What’s New with the FDA Labeling for Pregnancy and Lactation?

July 1, 2016
Talia Puzantian, PharmD, BCPP
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Talia PuzantianTalia Puzantian, PharmD, BCPP Deputy Editor, The Carlat Psychiatry Report Dr. Puzantian has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
We’ve been hearing for some time now about the FDA’s plans to revise the long-standing categories A, B, C, D, and X designations for risk of using medications in pregnancy. The new rule (referred to as PLLR for Pregnancy and Lactation Labeling Rule) was proposed in 2008, finalized in 2014, and implementation began during the summer of 2015.
Read More
EXPERT Q&A

How to Evaluate and Treat Mood Disorders in Pregnancy

July 1, 2016
Vivien Burt, PhD, MD
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Vivien Burt, PhD, MD

Founder and co-director at UCLA Women’s Life Center, a perinatal outpatient program in Los Angeles, CA.

Dr. Burt discloses that she has been a paid consultant to Otsuka, Sunovion, Lundbeck, and Takeda. Dr. Puzantian has reviewed this article and has found no evidence of bias in this educational activity.

Dr. Vivien Burt discusses mood disorders and pregnancy. It’s now pretty widely recognized that pregnancy does not protect against mental illness, and the postpartum period is certainly a time of very high vulnerability for women, especially if they’ve had a history of psychiatric illness.
Read More

New Study Supports Cardiac Safety of SSRIs in Pregnancy

July 1, 2014
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Concerns about the safety of psychiatric medications during pregnancy are common among psychiatrists and patients alike. In many cases, one must weigh the risks of a medication to mother or child against the risks inherent in untreated mental illness. Recent research, however, lends support to the growing data about the safety of antidepressant medications in pregnancy.
Read More

WHO Releases Guidelines on Perinatal Addiction

May 1, 2014
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
The World Health Organization has released evidence-based guidelines for healthcare professionals to help pregnant women who abuse alcohol or other drugs.
Read More

Marijuana During Pregnancy Could Miswire Babies’ Brain

February 18, 2014
Joanne Finnegan
...
Read More
More Articles Tagged with 'women's_issues_in_psychiatry'
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2603816031.jpg
    General Psychiatry

    A Scam for Every Woman, Child, and Man: Part 2

    1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.